2 Cathie Wood Stocks That Are Beating the Market This Year
Has famed investor Cathie Wood lost her touch? The CEO Of Ark Invest and her team crafted exchange-traded funds (ETFs) that destroyed the broader market during the early days of the pandemic, but over the past year, it's been the other way around. Still, it's far too premature to give up on Wood's ETFs, and it's also worth noting that some of her stock picks are performing better than most this year. Let's look at two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Incyte (NASDAQ: INCY).
Vertex Pharmaceuticals is close to hitting a new all-time high as the drugmaker's business is firing on all cylinders. The biotech's existing cystic fibrosis (CF) franchise, where it holds a monopoly, is still helping it deliver growing revenue and earnings. During the second quarter, Vertex Pharmaceuticals' top line jumped by 22% year over year to $2.20 billion.
Source Fool.com
